GTx, Inc. Information

GTx, Inc., headquartered in Memphis, Tennessee, is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostrate cancer, and other serious medical conditions.

Website	http://www.gtxinc.com
Ticker	GTXI
Revenue	$641000
Funding	$78.3 million
Employees	44 (5 on RocketReach)
Founded	1997
Address	175 Toyota Plz, Fl 7, Memphis, Tennessee 38103, US
Phone	+1 901-271-8733
Fax	(901) 844-8075
Technologies	JavaScript , HTML , PHP +10 more (view full list)
Industry	Biotechnology Research, Drug Manufacturing & Research, Biopharma, Pharmaceuticals, Biotechnology, Healthcare, Health Care, Science and Engineering
Web Rank	3 Million
Keywords	Cancer Treatment, Biopharmaceutical, Oncology, Cancer Therapeutics, Pharmaceutical, Drug Development, Biotechnology, Drug Discovery, Pharma, Small Molecule Drugs, Pharmaceutical Research, New Drug Discovery, Healthcare, Treatment, Medicine, Breast Cancer Treatment, Prostate Cancer Treatment, Therapeutic Agents, Clinical Trials, Medicinal Chemistry
Competitors	Sangamo Therapeutics, Inc., Akcea Therapeutics, Bristol Myers Squibb, Vertex Pharmaceuticals, AstraZeneca, Gilead Sciences, Amgen, Regeneron, Pfizer, Lilly India +45 more (view full list)
SIC	SIC Code 28 Companies, SIC Code 283 Companies
NAICS	NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies